Vanholder, Raymond http://orcid.org/0000-0003-2633-1636
Annemans, Lieven
Braks, Marion
Brown, Edwina A. http://orcid.org/0000-0002-4453-6486
Pais, Priya
Purnell, Tanjala S.
Sawhney, Simon http://orcid.org/0000-0002-7960-4573
Scholes-Robertson, Nicole http://orcid.org/0000-0001-8260-0453
Stengel, Bénédicte
Tannor, Elliot K. http://orcid.org/0000-0002-5978-0510
Tesar, Vladimir http://orcid.org/0000-0001-6982-0689
van der Tol, Arjan
Luyckx, Valérie A.
Article History
Accepted: 11 July 2023
First Online: 14 August 2023
Competing interests
: R.V. is an adviser to AstraZeneca, Glaxo Smith Kline, Fresenius Kabi, Novartis, Kibow, Baxter, Nipro, Fresenius Medical Care and Nextkidney. L.A. is an adviser to AstraZeneca and Baxter. E.A.B. is an adviser to Baxter, IiberDi and AWAK, and has received speaker fees from Baxter and Vifor. B.S. has received grant support from Glaxo Smith Kline, Fresenius Medical Care and Boehringer Ingelheim as part of the CKD-REIN study. V.A.L. receives royalties as a co-editor of “The Kidney” textbook. The other authors declare no competing interests.